+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

DDR defect tumors - Epidemiology Forecast - 2032 - Product Thumbnail Image

DDR defect tumors - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
HPV16-positive Anogenital Cancer - Epidemiology Forecast - 2032 - Product Thumbnail Image

HPV16-positive Anogenital Cancer - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
TRK Fusion Cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

TRK Fusion Cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Myeloproliferative Neoplasms - Epidemiology Forecast - 2032 - Product Thumbnail Image

Myeloproliferative Neoplasms - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Richter Syndrome - Epidemiology Forecast - 2032 - Product Thumbnail Image

Richter Syndrome - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Bone Metastasis in Solid Tumors - Epidemiology Forecast to 2032 - Product Thumbnail Image

Bone Metastasis in Solid Tumors - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hepatic Cirrhosis- Epidemiology Forecast to 2032 - Product Thumbnail Image

Hepatic Cirrhosis- Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Ovarian Cancer- Epidemiology Forecast to 2032 - Product Thumbnail Image

Ovarian Cancer- Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
From
From
Hodgkin Lmphoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hodgkin Lmphoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
HR-Positive-HER-negative - Epidemiology Forecast to 2032 - Product Thumbnail Image

HR-Positive-HER-negative - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
MALT Lymphoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

MALT Lymphoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
MDS - Epidemiology Forecast to 2032 - Product Thumbnail Image

MDS - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Merkel Cell Carcinoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Merkel Cell Carcinoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more